Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schoepp

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
CNS Spectrums|December 2, 2004
Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic functionJ D Coplan, S J Mathew, E L Smith, et al.
Neuropharmacology|January 1, 1997
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptorsD D Schoepp, B G Johnson, R A Wright, et al.
Neuropharmacology|January 1, 1996
Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profilesD Bleakman, B A Ballyk, D D Schoepp, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailabilityP L Ornstein, T J Bleisch, M B Arnold, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivoA Bond, N M Jones, C A Hicks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.
Journal of Medicinal Chemistry|July 19, 1996
Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclaseJ A Monn, M J Valli, B G Johnson, et al.
Nature|October 23, 1997
A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmissionV R Clarke, B A Ballyk, K H Hoo, et al.
Journal of Medicinal Chemistry|February 14, 1997
Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic propertiesJ A Monn, M J Valli, S M Massey, et al.
Journal of Medicinal Chemistry|March 26, 1999
Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptorsJ A Monn, M J Valli, S M Massey, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
CNS Spectrums|December 2, 2004
Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic functionJ D Coplan, S J Mathew, E L Smith, et al.
Neuropharmacology|January 1, 1997
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptorsD D Schoepp, B G Johnson, R A Wright, et al.
Neuropharmacology|January 1, 1996
Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profilesD Bleakman, B A Ballyk, D D Schoepp, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailabilityP L Ornstein, T J Bleisch, M B Arnold, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivoA Bond, N M Jones, C A Hicks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.
Journal of Medicinal Chemistry|July 19, 1996
Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclaseJ A Monn, M J Valli, B G Johnson, et al.
Nature|October 23, 1997
A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmissionV R Clarke, B A Ballyk, K H Hoo, et al.
Journal of Medicinal Chemistry|February 14, 1997
Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic propertiesJ A Monn, M J Valli, S M Massey, et al.
Journal of Medicinal Chemistry|March 26, 1999
Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptorsJ A Monn, M J Valli, S M Massey, et al.
Pageof 13